These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14522866)

  • 21. [Prion, from crazy cows to iatrogenic Creutzfeldt-Jakob disease. Which risk in laboratory or in hospital?].
    Paul J
    Pathol Biol (Paris); 1995 Feb; 43(2):114-20. PubMed ID: 7777380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reducing the risk of cross-contamination from transmissible spongiform encephalopathies.
    Brendle TA
    AORN J; 2005 Sep; 82(3):442-6. PubMed ID: 16309070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BSE: the final resting place.
    Brown P
    Lancet; 1998 Apr; 351(9110):1146-7. PubMed ID: 9643681
    [No Abstract]   [Full Text] [Related]  

  • 24. Transmissible spongiform encephalopathies: vaccine issues.
    Cashman NR
    Dev Biol (Basel); 2001; 106():455-9; discussion 460-1, 465-75. PubMed ID: 11761262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention of transmissible spongiform encephalopathy and methods for prion inactivation].
    Papacchini M; Mansi A; Marta I
    Med Lav; 2003; 94(3):271-84. PubMed ID: 12918319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Transmissible spongiform encephalopathies in animals].
    Fatzer R; Vandevelde M
    Wien Med Wochenschr; 1998; 148(4):78-85. PubMed ID: 9611347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostics for TSE agents.
    Raeber AJ; Oesch B
    Dev Biol (Basel); 2006; 123():313-23; discussion 349-54. PubMed ID: 16566455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human transmissible spongiform encephalopathies: historic view.
    Asher DM; Gregori L
    Handb Clin Neurol; 2018; 153():1-17. PubMed ID: 29887130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical transmissible spongiform encephalopathies (TSEs) in ruminants.
    Baron T; Biacabe AG; Arsac JN; Benestad S; Groschup MH
    Vaccine; 2007 Jul; 25(30):5625-30. PubMed ID: 17126958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Working with transmissible spongiform encephalopathy agents.
    Brown P; Abee CR
    ILAR J; 2005; 46(1):44-52. PubMed ID: 15644563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prions: where do we stand 20 years after the appearance of bovine spongiform encephalopathy?].
    Crozet C; Lehmann S
    Med Sci (Paris); 2007 Dec; 23(12):1148-57. PubMed ID: 18154718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The research programme on transmissible spongiform encephalopathies in Britain with special reference to bovine spongiform encephalopathy.
    Bradley R
    Dev Biol Stand; 1993; 80():157-70. PubMed ID: 8270105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prion disease as infectious disease transmissible from animals to human].
    Horiuchi M
    Nihon Rinsho; 2005 Dec; 63(12):2213-20. PubMed ID: 16363697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transmissible spongiform encephalopathies in humans.
    Belay ED
    Annu Rev Microbiol; 1999; 53():283-314. PubMed ID: 10547693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease.
    Casalone C; Zanusso G; Acutis P; Ferrari S; Capucci L; Tagliavini F; Monaco S; Caramelli M
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3065-70. PubMed ID: 14970340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The transmissible spongiform encephalopathy agents: concerns and responses of United States regulatory agencies in maintaining the safety of biologics.
    Asher DM
    Dev Biol Stand; 1999; 100():103-18. PubMed ID: 10616181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hospital practice and prion risks].
    Darbord JC; Hauw JJ
    Pathol Biol (Paris); 2005 May; 53(4):237-43. PubMed ID: 15850958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquired prion disease: iatrogenic CJD, variant CJD, kuru.
    Will RG
    Br Med Bull; 2003; 66():255-65. PubMed ID: 14522863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prion diseases and iatrogenic infections II. Decontamination.
    Jung M; Pistolesi D; Panà A
    Ig Sanita Pubbl; 2005; 61(4):379-410. PubMed ID: 17242715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transmissible spongiform encephalopathies (TSE): minimizing the risk of transmission by biological/biopharmaceutical products: an industry perspective.
    Kozak RW; Golker CF; Stadler P
    Dev Biol Stand; 1996; 88():257-64. PubMed ID: 9119148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.